
News|Articles|June 1, 2002
Part 2: Beyond depression: Evaluation of newer indications and off-label uses for SSRIs (PDF)
In this final installment of this series, the authors focus on the use of SSRIs in alcohol dependence, chronic pain, eating disorders, premenstrual dysphoric disorder, and sexual dysfunction. For each condition, the authors examine how well clinical trial evidence supports the application, discuss dosing and safety considerations, and provide their recommendations on preferred and alternative SSRIs, based on the weight of the evidence.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Insights from the AMCP Nexus 2025 Meeting
2
The Shift in Star Ratings That Health Plans Can't Ignore
3
Clinical and Economic Impact of OAB Symptoms in Men Receiving Pharmacological Treatment for BPH
4
MHE Week in Review – HPV Vaccine Still Effective, Dry Eye Disease Lacks Effective Treatments and More
5

















































